- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0020040

Cospex Pharmaceuticals Private Limited
About Cospex Pharmaceuticals Private Limited
Data last updated:
Cospex Pharmaceuticals Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74999CH2018PTC041898. Its GSTIN is 04AAHCC4493M1ZB (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nidhi Saini and Ajaypal Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No 263 Motor Market & Commercial Complex, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.13 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.05 Lakh (net margin 1.8%) and EBITDA of ₹2.78 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 36% over five years.
Cospex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0020040).
Company details
Recognitions & Rankings of Cospex Pharmaceuticals
Contact details
Cospex Pharmaceuticals Private Limited's registered office is in Manimajra, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressScf No 263 Motor Market & Commercial Complex, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cospex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cospex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cospex Pharmaceuticals Private Limited, buy the company report.
Financials of Cospex Pharmaceuticals Private Limited
FY 2025 filings availableCospex Pharmaceuticals Private Limited reported revenue of ₹1.13 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 36%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cospex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cospex Pharmaceuticals Private Limited
Cospex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidhi Saini | Director | 09 Mar 2018 | 8 Years 7 Months | Current |
| Ajaypal Singh | Director | 09 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Cospex Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cospex Pharmaceuticals Private Limitedthis company | ₹1.13 Cr (FY 2024) | ₹2.05 Lakh | 1.8% | -11.0% | Manimajra, Chandigarh, India | |
| Exalt Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2025) | -25.0% | Faridabad, Haryana, India | |||
| Myren Life Science India Private Limited | ₹1.13 Cr (FY 2021) | -64.0% | Hyderabad, Telangana, India | |||
| Servigen Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Wellyz Pharmaceutical Private Limited | ₹1.13 Cr (FY 2025) | 2.0% | Durgapur Mc, West Bengal, India | |||
| Ambiens Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 119.0% | Csa, Uttar Pradesh, India |
To see the full peer comparison of Cospex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cospex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cospex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cospex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAHCC4493M1ZB | Chandigarh | Active | 16 Mar 2018 |
To see the full GST registrations and return filing status of Cospex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cospex Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ajaypal Singh was appointed as Director on 09 Mar 2018.
Frequently asked questions
Cospex Pharmaceuticals is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2018 (8+ years old) and is registered under CIN U74999CH2018PTC041898.
Cospex Pharmaceuticals has 2 current directors:
- Nidhi Saini - Director
- Ajaypal Singh - Director
The latest financial statements of Cospex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cospex Pharmaceuticals is 04AAHCC4493M1ZB, registered in Chandigarh.
The CIN (Corporate Identification Number) of Cospex Pharmaceuticals is U74999CH2018PTC041898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cospex Pharmaceuticals was incorporated on 09 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Cospex Pharmaceuticals by revenue are Exalt Pharmaceuticals Private Limited, Myren Life Science India Private Limited, Servigen Pharmaceuticals Private Limited, Wellyz Pharmaceutical Private Limited, Ambiens Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajaypal Singh was appointed as Director on 09 Mar 2018. Nidhi Saini was appointed as Director on 09 Mar 2018.
Yes, Cospex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0020040).
The registered office of Cospex Pharmaceuticals is at Scf No 263 Motor Market & Commercial Complex, Manimajra, Chandigarh, India – 160101.
Cospex Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

